{"id":"sevorane-sevoflurane-abbott","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Postoperative nausea and vomiting"},{"rate":"5-15","effect":"Emergence delirium"},{"rate":"10-20","effect":"Hypotension"},{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"Hepatotoxicity (rare)"}]},"_chembl":{"chemblId":"CHEMBL1200694","moleculeType":"Small molecule","molecularWeight":"200.05"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sevoflurane is a halogenated ether that acts as a general anesthetic by modulating ion channels and neurotransmitter receptors in the brain, particularly potentiating GABA-A receptors and blocking NMDA glutamate receptors. This results in rapid loss of consciousness, amnesia, and analgesia. It is administered via inhalation and is rapidly absorbed and eliminated through the lungs, making it suitable for induction and maintenance of general anesthesia.","oneSentence":"Sevoflurane is a volatile anesthetic that depresses the central nervous system by enhancing inhibitory GABA neurotransmission and inhibiting excitatory glutamate signaling.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:07:42.978Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Induction and maintenance of general anesthesia in adults and pediatric patients"},{"name":"Sedation in intensive care settings"}]},"trialDetails":[{"nctId":"NCT00541918","phase":"PHASE4","title":"COGNITIVE - Cognitive Function After Sevoflurane or Propofol Anesthesia for Open-heart Operations","status":"WITHDRAWN","sponsor":"Medical University of Gdansk","startDate":"2007-06","conditions":"Other Functional Disturbances Following Cardiac Surgery, Memory Disorders","enrollment":""},{"nctId":"NCT02429323","phase":"NA","title":"Endotracheal Intubation With Sevoflurane in Surgical Pediatric Patients","status":"COMPLETED","sponsor":"University of Sulaimani","startDate":"2011-06","conditions":"Anesthesia; Reaction","enrollment":100},{"nctId":"NCT01374633","phase":"PHASE2","title":"Sevoflurane Sedation on Intra Cranial Pressure in Traumatic Brain Injury Patients","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2011-12","conditions":"Brain Injury","enrollment":10},{"nctId":"NCT01792063","phase":"PHASE4","title":"Two Different Preparations of Sevoflurane in Induction","status":"COMPLETED","sponsor":"Istanbul University","startDate":"2013-02","conditions":"Coughing on Induction, Vapors; Inhalation","enrollment":200},{"nctId":"NCT00586118","phase":"","title":"Inhalative Sedation in ICU With Sevoflurane Via Anaesthetic Conserving Device Compared to Propofol","status":"COMPLETED","sponsor":"Klinikum Ludwigshafen","startDate":"2006-12","conditions":"Recovery From Sedation, Sevoflurane Consumption, Renal Function","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["sevoflurane"],"phase":"marketed","status":"active","brandName":"Sevorane (sevoflurane, Abbott)","genericName":"Sevorane (sevoflurane, Abbott)","companyName":"Medical University of Gdansk","companyId":"medical-university-of-gdansk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sevoflurane is a small molecule that acts as a positive modulator of the glycine receptor (alpha-1/beta). It is used for inhalative sedation in ICU settings, with studies comparing its effects to propofol.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}